Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine 3% Gel vs Oxybuprocaine 0.4% Eye Drops in Pediatrics
NCT05926258Phase 3Completed
- Sponsor
- Sintetica
- Start
- May 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
A Phase 3 trial of chloroprocaine in ocular surface anesthesia, sponsored by Sintetica. Started May 2024; status: completed.
02
Drugs
chloroprocaine
03
Conditions
ocular surface anesthesia
Beyond the preview
Go deeper on NCT05926258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926258.